Impact of frontline treatment approach on outcomes in patients with secondary AML with prior hypomethylating agent exposure

BACKGROUND: Treated secondary acute myeloid leukemia (ts-AML)—i.e., AML arising from a previously treated antecedent hematologic disorder—is associated with very poor outcomes. The optimal frontline treatment regimen for these patients is uncertain. METHODS: We retrospectively analyzed 562 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Short, Nicholas J., Venugopal, Sangeetha, Qiao, Wei, Kadia, Tapan M., Ravandi, Farhad, Macaron, Walid, Dinardo, Courtney D., Daver, Naval, Konopleva, Marina, Borthakur, Gautam, Shpall, Elizabeth J., Popat, Uday, Champlin, Richard E., Mehta, Rohtesh, Al-Atrash, Gheath, Oran, Betul, Jabbour, Elias, Garcia-Manero, Guillermo, Issa, Ghayas C., Montalban-Bravo, Guillermo, Yilmaz, Musa, Maiti, Abhishek, Kantarjian, Hagop
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800349/
https://www.ncbi.nlm.nih.gov/pubmed/35093134
http://dx.doi.org/10.1186/s13045-022-01229-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800349/
https://www.ncbi.nlm.nih.gov/pubmed/35093134
http://dx.doi.org/10.1186/s13045-022-01229-z

Ejemplares similares